Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New membrane for cell encapsulation.

K Tatarkiewicz1

  • 1Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw.

Artificial Organs
|October 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.

Diabetes, obesity & metabolism·2014
Same author

The glucagon-like peptide-1-based therapeutics exenatide and saxagliptin did not cause detrimental effects on the pancreas in mice, rats, dogs and monkeys.

Diabetes, obesity & metabolism·2014
Same author

Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice.

Diabetes, obesity & metabolism·2013
Same author

A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents.

Diabetes, obesity & metabolism·2013
Same author

No evidence of drug-induced pancreatitis in rats treated with exenatide for 13 weeks.

Diabetes, obesity & metabolism·2012
Same author

Considerations for successful transplantation of encapsulated pancreatic islets.

Diabetologia·2002
Same journal

Large-Eddy Simulation of the FDA Benchmark Blood Pump: Validation Against Experiments and Implications for Turbulent Flow Mechanisms.

Artificial organs·2026
Same journal

The Warm Revolution: A Meta-Analysis of DCD Versus DBD Liver Transplant Outcomes in the Normothermic Machine Perfusion Era.

Artificial organs·2026
Same journal

Toward Optimal Remote Monitoring in LVAD Recipients: Remaining Challenges Beyond Feasibility.

Artificial organs·2026
Same journal

Advancing Organ Preservation and Perfusion: Introducing the International Society of Organ Preservation and Perfusion Therapy (ISOPPT).

Artificial organs·2026
Same journal

Short Inter-Treatment Interval Treatment With Artificial Liver Support System Reduces 90-Day Transplant-Free Mortality in Patients With Hepatitis B Virus-Related Acute-On-Chronic Liver Failure: A Retrospective Observational Study.

Artificial organs·2026
Same journal

Extracorporeal Albumin Dialysis (OPAL) as Novel Therapeutic Bridging Option in Posthepatectomy Liver Failure.

Artificial organs·2026
See all related articles

A novel biocompatible membrane for microencapsulating Langerhans islets was developed using polyethyleneimine, heparin, and protamine sulfate. This membrane allows easy diffusion of glucose and insulin while blocking larger proteins, showing promise for islet transplantation.

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Biotechnology

Background:

  • Microencapsulation is crucial for protecting transplanted cells, particularly Langerhans islets, from immune rejection.
  • Developing biocompatible and selectively permeable membranes is essential for successful islet transplantation.
  • Existing methods face challenges in balancing cell protection with nutrient/waste exchange.

Purpose of the Study:

  • To develop and characterize a new biocompatible membrane for microencapsulating Langerhans islets.
  • To evaluate the permeability properties of the novel membrane for key biological molecules.
  • To assess the suitability of the membrane for potential therapeutic applications in diabetes.

Main Methods:

  • Membrane preparation using polyethyleneimine, heparin, and protamine sulfate for enhanced biocompatibility.

Related Experiment Videos

  • Permeability studies based on Fick's law of diffusion, analyzing transport across the membrane.
  • Testing diffusion of glucose, insulin, human albumin, and gamma-globulins through the microcapsules.

    • Main Results:

    • The developed membrane demonstrated good biocompatibility properties due to its composition.
    • Fick's law analysis confirmed that glucose and insulin can easily diffuse into and out of the microcapsules.
    • The membrane exhibited impermeability to larger proteins such as human albumin and gamma-globulins.

    Conclusions:

    • The novel polyethyleneimine-based membrane offers selective permeability suitable for Langerhans islet microencapsulation.
    • The membrane's ability to facilitate glucose and insulin transport while excluding large proteins is advantageous for islet survival and function.
    • This biomaterial presents a promising advancement for immunoisolation strategies in islet transplantation therapy.